8% of patients treated with anticoagulation, tended to
decrease over time, perhaps reflecting improved thrombolytic techniques and more rigorous exclusion criteria. Finally, a pooled analysis of 19 studies, largely single-center
case series, reported major bleeding in a mean of 8.3% of
patients (range, 0%-24%) and rates of symptomatic PE,
intracranial hemorrhage, and death of 0.9% (range,